Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma

Cetuximab, a monoclonal antibody against the epidermal growth factor receptor (EGFR), has been successfully used to treat some patients with colorectal cancer and those with head and neck squamous cell carcinoma (HNSCC). For the effective treatment, it is essential to first identify cetuximab-respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, T, Ozawa, S, Ikoma, T, Yang, X-Y, Kanamori, K, Suzuki, K, Iwabuchi, H, Maehata, Y, Miyamoto, C, Taguchi, T, Kiyono, T, Kubota, E, Hata, R-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399171/
https://www.ncbi.nlm.nih.gov/pubmed/27399917
http://dx.doi.org/10.1038/oncsis.2016.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399171/
https://www.ncbi.nlm.nih.gov/pubmed/27399917
http://dx.doi.org/10.1038/oncsis.2016.43

Ejemplares similares